CYTOGENETIC CHARACTERIZATION OF CHRONIC MYELOID LEUKEMIA AND ITS PROGNOSTIC IMPACT UPON TREATMENT WITH TYROSINE KINASE INHIBITORS

被引：0

作者：

Canamero, Giro Eloi ^{[1
]}

Garcia, Olga ^{[1
]}

Boque, Concepcion ^{[2
]}

Sitges, Marta ^{[3
]}

Vallansot, Rolando Omar ^{[4
]}

Cisneros, Adela ^{[1
]}

Cortes, Montserrat ^{[5
]}

Gener, Georgina ^{[6
]}

Vela, Dolors ^{[7
]}

Font, Llorenc ^{[8
]}

Pineda, Alberto ^{[9
]}

Xandri, Marisol ^{[1
]}

Santafe, Encarnacion ^{[1
]}

Espasa, Andrea ^{[1
]}

Comes, Martina ^{[1
]}

Xicoy, Blanca ^{[1
]}

Zamora, Lurdes ^{[1
]}

Granada, Isabel ^{[1
]}

Navarro, Jose Tomas ^{[1
]}

Grau, Javier ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Inst Catala Oncol, Inst Recerca Leucemia Josep Carreras, Barcelona, Spain

[2] ICO Hosp Duran & Reynals, Lhospitalet De Llobregat, Spain

[3] ICO Hosp Univ Josep Trueta, Girona, Spain

[4] Hosp Univ Joan XXIII, Tarragona, Spain

[5] Hosp Granollers, Granollers, Spain

[6] Hosp Mataro, Mataro, Spain

[7] Hosp Mollet del Valles, Mollet, Spain

[8] Hosp Verge de la Cinta, Tortosa, Spain

[9] Hosp Esperit St, Santa Coloma, Spain

来源：

HAEMATOLOGICA | 2020年 / 105卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO-057

引用

页码：169 / 170

页数：2

共 50 条

[41] NEW AND ESTABLISHED TYROSINE KINASE INHIBITORS FOR CHRONIC MYELOID LEUKEMIA
Thienelt, C. D.
Green, K.
Bowles, D. W.
DRUGS OF TODAY, 2012, 48 (09) : 601 - 613
[42] Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
Ciaffaglione, Valeria
Consoli, Valeria
Intagliata, Sebastiano
Marrazzo, Agostino
Romeo, Giuseppe
Pittala, Valeria
Greish, Khaled
Vanella, Luca
Floresta, Giuseppe
Rescifina, Antonio
Salerno, Loredana
Sorrenti, Valeria
MOLECULES, 2022, 27 (10):
[43] Tyrosine kinase inhibitors concentration monitoring in chronic myeloid leukemia
Widmer, N.
Gotta, V.
Haouala, A.
Decosterd, L. A.
LEUKEMIA RESEARCH, 2010, 34 (06) : 698 - 699
[44] Chronic myeloid leukemia and new tyrosine kinase inhibitors: confirmation
Mahon, Francois-Xavier
HEMATOLOGIE, 2006, 12 : 43 - 46
[45] Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia
Leonardo Campiotti
Elena Bolzacchini
Matteo Basilio Sutter
Andrea Maria Maresca
Anna Maria Grandi
Luigina Guasti
Internal and Emergency Medicine, 2018, 13 : 1337 - 1339
[46] Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia
Pepeler, Mehmet Sezgin
Tiglioglu, Mesut
Dagdas, Simten
Ozhamamcioglu, Esra
Han, Unsal
Albayrak, Aynur
Aydin, Muruvvet Seda
Korkmaz, Guelten
Pamukcuoglu, Merve
Ceran, Funda
Albayrak, Murat
Ozet, Gulsum
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (04): : e161 - e167
[47] Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors
Kong, Jee Hyun
Winton, Elliott F.
Heffner, Leonard T.
Gaddh, Manila
Hill, Brittany
Neely, Jessica
Hatcher, Angela
Joseph, Meena
Arellano, Martha
El-Rassi, Fuad
Kim, Audrey
Khoury, Jean Hanna
Kota, Vamsi K.
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
[48] Outcomes after Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Phase Chronic Myeloid Leukemia
Kong, Jee Hyun
Winton, Elliott F.
Heffner, Leonard
Gaddh, Manila
Hill, Brittany
Arellano, Martha
El-Rassi, Fuad
Kim, Audrey
Jillella, Anand
Kota, Vamsi K.
BLOOD, 2017, 130
[49] Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia
Valentin Garcia-Gutierrez, J.
Herrera, Pilar
Abalo, Lorena L.
Dolores Rey, Maria
Calbacho, Maria
Ramos, Lourdes
Ramos, Paloma
Montalban, Carlos
Lopez-Jimenez, Javier
BLOOD, 2011, 118 (21) : 1615 - 1615
[50] Tyrosine kinase inhibitors (TKI): a new revolution in the treatment of chronic myeloid leukemia (CML)
Aviles-Vazquez, Socrates
Chavez-Gonzalez, Antonieta
Mayani, Hector
GACETA MEDICA DE MEXICO, 2013, 149 (06): : 646 - 654

← 1 2 3 4 5 →